Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing

House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99M
House joins Senate in rejecting Trump’s proposed 40% NIH cuts

Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost

With CDC in free fall, RFK Jr. faces bipartisan rebuke at Senate hearing
Kennedy calls CDC “the most corrupt agency at HHS and maybe the government.”

Curing cancer or curbing immigration: A question of national morality and priority

Cancer Policy

The departure (and return) of Vinay Prasad

Trump administration wants to rebuild stockpile of APIs to address drug shortages

Trump administration unlawfully terminated grants from Harvard, federal judge rules

FDA will speed up public release of Complete Response Letters

ACOG says it will no longer accept federal funding

Trump administration broke law by canceling DEI research grants, GAO finds

Clinical Roundup

City of Hope study shows childhood cancer survivors face new health problems later in life

MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds

Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

CAR T-cell therapy clinical trial debuts at KU Cancer Center

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

Decipher Prostate Test predicts chemo benefit in metastatic prostate cancer, phase III trial shows

In The Clinic

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

An overlooked immune cell population may offer new direction for cell and gene therapy

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

Latest Issue

NEWS ALERTS

Stay up to date on the latest news in oncology by joining our mailing list.

UPCOMING EVENTS

Sep 2025

Oct 2025

Conversations with The Cancer Letter

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

Contributors

Vijay Trisal, MD

Angus (Gus) Reid

Louis M. Weiner, MD

Barnett Kramer, MD, MPH

Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing

House committee’s FY26 spending bill increases NCI funding by $48M, NIH by $99M
House joins Senate in rejecting Trump’s proposed 40% NIH cuts

Lowy: Forward-funding policy forced NCI to drastically reduce RPG awards funded for FY25, 10% of NCI staff has been lost

With CDC in free fall, RFK Jr. faces bipartisan rebuke at Senate hearing
Kennedy calls CDC “the most corrupt agency at HHS and maybe the government.”

Curing cancer or curbing immigration: A question of national morality and priority

The departure (and return) of Vinay Prasad

Trump administration wants to rebuild stockpile of APIs to address drug shortages

Trump administration unlawfully terminated grants from Harvard, federal judge rules

FDA will speed up public release of Complete Response Letters

ACOG says it will no longer accept federal funding

Trump administration broke law by canceling DEI research grants, GAO finds

City of Hope study shows childhood cancer survivors face new health problems later in life

MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds

Off-the-shelf cancer vaccine elicits strong immune response in patients with pancreatic and colorectal cancer

CAR T-cell therapy clinical trial debuts at KU Cancer Center

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

Decipher Prostate Test predicts chemo benefit in metastatic prostate cancer, phase III trial shows

Will MCD tests revolutionize cancer screening? NCI begins enrollment in Vanguard “feasibility” trial to start finding out

First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI

An overlooked immune cell population may offer new direction for cell and gene therapy

She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research

How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

Vijay Trisal, MD

Angus (Gus) Reid

Louis M. Weiner, MD

Barnett Kramer, MD, MPH

Never miss an issue!

Login

Bhattacharya fields NCAB’s questions about funding, political involvement in grant review, DEI, animal testing

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSUBrian Druker returns to executive role as president of the new Knight Cancer Group

Robert Winn: If Medicaid gets massive cuts or goes away, where will these patients get care?

HHS seems poised to exert control over USPSTFRansohoff: The task force is the pinnacle of evidence-based medicine

Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures

Angus (Gus) Reid

Never miss an issue!

Login

Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group

HHS seems poised to exert control over USPSTF
Ransohoff: The task force is the pinnacle of evidence-based medicine